49
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

A Comparative Study of Monoclonal Antibodies (Mabs) Purified from Cell Culture Supernatant on EDTPA‐Modified Zirconia Beads and Protein A‐Hyper D Support

, , , &
Pages 471-484 | Received 03 Sep 2005, Accepted 02 Oct 2005, Published online: 06 Feb 2007
 

Abstract

Colloidal zirconia was spray dried to yield zirconia particles, which were further modified with N, N, N′, N′‐ Ethylenediamine tetra methylenephosphonic acid (EDTPA) to yield a support for use in bioseparations. EDTPA modified zirconia particles will be further referred to as, r_PEZ. Cell culture supernatants rich in monoclonal antibody (Mab) subtypes IgG1, IgG2a, IgG2b, and IgG3 were chromatographed on a r_PEZ column, and on a protein A‐hyper D column that was purchased commercially. All Mab subtypes bound to r_PEZ and process yields in the range of 88 to 99% were obtained. The purity of the Mab products were ascertained by gel electrophoretic analysis and were estimated to be greater than 95%. The purified Mab products obtained from r_PEZ and protein A columns were compared to the reference Mab standard in biological and enzymatic assays. The value of the dissociation constant (Kd) was found to be comparable and was in the range to that obtained with reference Mab standard (0.231±0.03 M). In addition, Mabs purified with r_PEZ had the same deglycosylation profile as the reference Mab standard. Thus, it appears that the r_PEZ purified Mab is similar in activity to Mab purified with a protein A support and in addition, the zirconia surface does not adversely impact the activity of the purified Mab.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.